Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-03 9:00 pm Purchase | 2026-07-30 | 13D | MAPLIGHT THERAPEUTICS INC MPLT | Catalyst4, Inc. | 20,906,689 47.900% | 1,209,225 (+6.14%) | Filing History |
| 2026-07-31 09:25 am Sale | 2026-07-30 | 13D | MAPLIGHT THERAPEUTICS INC MPLT | Novo Holdings A/S | 2,086,622 4.900% | -1,600,000 (-43.40%) | Filing History |
| 2026-05-15 10:06 am Purchase | 2026-03-31 | 13G | MAPLIGHT THERAPEUTICS INC MPLT | T. Rowe Price Investment Management, Inc. | 8,741,432 7.400% | 1,015,134 (+13.14%) | Filing History |
| 2026-02-17 10:28 am Purchase | 2025-12-31 | 13G | MAPLIGHT THERAPEUTICS INC MPLT | T. Rowe Price Investment Management, Inc. | 7,726,298 6.200% | 7,726,298 (New Position) | Filing History |
| 2026-02-17 08:31 am Purchase | 2025-12-31 | 13G | MAPLIGHT THERAPEUTICS INC MPLT | Forbion Growth Opportunities Fund III Cooperatief U.A. | 3,226,400 7.100% | 3,226,400 (New Position) | Filing History |
| 2025-11-20 7:37 pm Purchase | 2025-10-28 | 13D | MAPLIGHT THERAPEUTICS INC MPLT | Catalyst4, Inc. | 19,697,464 45.100% | 19,697,464 (New Position) | Filing History |
| 2025-11-04 4:21 pm Purchase | 2025-10-28 | 13D | MAPLIGHT THERAPEUTICS INC MPLT | Novo Holdings A/S | 3,686,622 8.400% | 3,686,622 (New Position) | Filing History |